{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:21:33Z","timestamp":1791591693013,"version":"4.3.4"},"reference-count":31,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Neurol"],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1001\/jamaneurol.2018.4377","type":"journal-article","created":{"date-parts":[[2019,1,14]],"date-time":"2019-01-14T11:43:43Z","timestamp":1547466223000},"page":"470","source":"Crossref","is-referenced-by-count":303,"title":["Prognosis and Neuropathologic Correlation of Clinical Subtypes of Parkinson Disease"],"prefix":"10.1001","volume":"76","author":[{"given":"Eduardo","family":"De Pablo-Fern\u00e1ndez","sequence":"first","affiliation":[{"name":"Reta Lila Weston Institute of Neurological Studies, University College London Queen Square Institute of Neurology, London, England"},{"name":"Queen Square Brain Bank for Neurological Disorders, University College London Queen Square Institute of Neurology, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Lees","sequence":"additional","affiliation":[{"name":"Reta Lila Weston Institute of Neurological Studies, University College London Queen Square Institute of Neurology, London, England"},{"name":"Queen Square Brain Bank for Neurological Disorders, University College London Queen Square Institute of Neurology, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janice L.","family":"Holton","sequence":"additional","affiliation":[{"name":"Queen Square Brain Bank for Neurological Disorders, University College London Queen Square Institute of Neurology, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas T.","family":"Warner","sequence":"additional","affiliation":[{"name":"Reta Lila Weston Institute of Neurological Studies, University College London Queen Square Institute of Neurology, London, England"},{"name":"Queen Square Brain Bank for Neurological Disorders, University College London Queen Square Institute of Neurology, London, England"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"2","key":"noi180100r1","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1007\/PL00007856","article-title":"The heterogeneity of idiopathic Parkinson\u2019s disease.","volume":"249","author":"Foltynie","year":"2002","journal-title":"J Neurol"},{"issue":"4","key":"noi180100r2","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/jnnp-2012-303455","article-title":"Parkinson\u2019s disease subtypes: lost in translation?","volume":"84","author":"Marras","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"noi180100r3","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11910-017-0738-x","article-title":"Subtypes of Parkinson\u2019s disease: what do they tell us about disease progression?","volume":"17","author":"Fereshtehnejad","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"8","key":"noi180100r4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1001\/jamaneurol.2015.0703","article-title":"New clinical subtypes of Parkinson disease and their longitudinal progression: a prospective cohort comparison with other phenotypes.","volume":"72","author":"Fereshtehnejad","year":"2015","journal-title":"JAMA Neurol"},{"issue":"7","key":"noi180100r5","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1093\/brain\/awx118","article-title":"Clinical criteria for subtyping Parkinson\u2019s disease: biomarkers and longitudinal progression.","volume":"140","author":"Fereshtehnejad","year":"2017","journal-title":"Brain"},{"issue":"1","key":"noi180100r6","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/mds.23346","article-title":"Clinical subtypes of Parkinson\u2019s disease.","volume":"26","author":"van Rooden","year":"2011","journal-title":"Mov Disord"},{"key":"noi180100r7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.parkreldis.2016.04.026","article-title":"Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease.","volume":"28","author":"Erro","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"8","key":"noi180100r8","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1002\/mds.26510","article-title":"Nonmotor features of Parkinson\u2019s disease subtypes.","volume":"31","author":"Marras","year":"2016","journal-title":"Mov Disord"},{"key":"noi180100r9","doi-asserted-by":"crossref","DOI":"10.1136\/jnnp-2018-318337","article-title":"Developing and validating Parkinson\u2019s disease subtypes and their motor and cognitive progression.","author":"Lawton","year":"2018","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"pt 11","key":"noi180100r10","doi-asserted-by":"publisher","first-page":"2947","DOI":"10.1093\/brain\/awp234","article-title":"A clinico-pathological study of subtypes in Parkinson\u2019s disease.","volume":"132","author":"Selikhova","year":"2009","journal-title":"Brain"},{"issue":"4","key":"noi180100r11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","article-title":"The Parkinson\u2019s Progression Marker Initiative (PPMI).","volume":"95","author":"Parkinson\u2019s Progression Marker Initiative","year":"2011","journal-title":"Prog Neurobiol"},{"issue":"1","key":"noi180100r12","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1212\/WNL.0000000000004058","article-title":"Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium.","volume":"89","author":"McKeith","year":"2017","journal-title":"Neurology"},{"issue":"8","key":"noi180100r13","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1001\/jamaneurol.2017.1125","article-title":"Association of autonomic dysfunction with disease progression and survival in Parkinson disease.","volume":"74","author":"De Pablo-Fernandez","year":"2017","journal-title":"JAMA Neurol"},{"issue":"pt 6","key":"noi180100r14","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/brain\/awq059","article-title":"Relationships between age and late progression of Parkinson\u2019s disease: a clinico-pathological study.","volume":"133","author":"Kempster","year":"2010","journal-title":"Brain"},{"issue":"pt 5","key":"noi180100r15","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1093\/brain\/awn065","article-title":"Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.","volume":"131","author":"O\u2019Sullivan","year":"2008","journal-title":"Brain"},{"issue":"2","key":"noi180100r16","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease.","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol Aging"},{"issue":"6","key":"noi180100r17","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s00401-009-0523-2","article-title":"Staging\/typing of Lewy body related alpha-synuclein pathology: a study of the BrainNet Europe Consortium.","volume":"117","author":"Alafuzoff","year":"2009","journal-title":"Acta Neuropathol"},{"issue":"4","key":"noi180100r18","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry.","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol"},{"issue":"4","key":"noi180100r19","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1750-3639.2008.00147.x","article-title":"Staging of neurofibrillary pathology in Alzheimer\u2019s disease: a study of the BrainNet Europe Consortium.","volume":"18","author":"Alafuzoff","year":"2008","journal-title":"Brain Pathol"},{"issue":"12","key":"noi180100r20","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD.","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"issue":"4","key":"noi180100r21","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD), part II: standardization of the neuropathologic assessment of Alzheimer\u2019s disease.","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"issue":"1","key":"noi180100r22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: a practical approach.","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol"},{"issue":"15","key":"noi180100r23","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease.","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov Disord"},{"issue":"4","key":"noi180100r24","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1097\/WCO.0000000000000219","article-title":"Subtypes of Parkinson\u2019s disease: state of the field and future directions.","volume":"28","author":"Marras","year":"2015","journal-title":"Curr Opin Neurol"},{"issue":"8","key":"noi180100r25","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1002\/mds.23116","article-title":"The identification of Parkinson\u2019s disease subtypes using cluster analysis: a systematic review.","volume":"25","author":"van Rooden","year":"2010","journal-title":"Mov Disord"},{"issue":"1","key":"noi180100r26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1002\/mds.25652","article-title":"Relation of clinical subtypes in Parkinson\u2019s disease with survival.","volume":"29","author":"de Lau","year":"2014","journal-title":"Mov Disord"},{"issue":"8","key":"noi180100r27","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1212\/WNL.57.8.1497","article-title":"Improved accuracy of clinical diagnosis of Lewy body Parkinson\u2019s disease.","volume":"57","author":"Hughes","year":"2001","journal-title":"Neurology"},{"issue":"5","key":"noi180100r28","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1212\/WNL.0000000000000641","article-title":"Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study.","volume":"83","author":"Adler","year":"2014","journal-title":"Neurology"},{"issue":"pt 8","key":"noi180100r29","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.1093\/brain\/awm142","article-title":"Patterns of levodopa response in Parkinson\u2019s disease: a clinico-pathological study.","volume":"130","author":"Kempster","year":"2007","journal-title":"Brain"},{"issue":"4","key":"noi180100r30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","article-title":"The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease.","volume":"115","author":"Halliday","year":"2008","journal-title":"Acta Neuropathol"},{"issue":"pt 5","key":"noi180100r31","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awr031","article-title":"Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important?","volume":"134","author":"Compta","year":"2011","journal-title":"Brain"}],"container-title":["JAMA Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamaneurology\/article-pdf\/76\/4\/470\/17436068\/jamaneurology_de_pablofernndez_2019_oi_180100.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,13]],"date-time":"2024-07-13T21:58:00Z","timestamp":1720907880000},"score":1,"resource":{"primary":{"URL":"http:\/\/archneur.jamanetwork.com\/article.aspx?doi=10.1001\/jamaneurol.2018.4377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaneurol.2018.4377","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.734858324.793556867","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.734858324.793578828","asserted-by":"object"}]},"ISSN":["2168-6149"],"issn-type":[{"value":"2168-6149","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4,1]]}}}